News from Cancer: Disparities in head and neck cancer patients

	Tweet

A new analysis finds considerable disparities in survival related to race and socio-economic status among patients with head and neck cancer. Published in the November 15, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that earlier diagnosis and greater access to treatment could improve outcomes for these cancers among African Americans and the poor.

A number of studies have examined disparities in cancer survival among different groups to help identify interventions to improve patient outcomes. To investigate factors that impact survival from head and neck cancer, Dr. Leonidas Koniaris and colleagues at the University of Miami School of Medicine reviewed all head and neck cancer cases in Florida between 1998 and 2002. By mining information from the Florida Cancer Data System and the Florida Agency for Health Care Administration dataset, they were able to accumulate data on diagnoses, comorbid conditions, and procedures performed during every hospitalization or outpatient visit among 20,915 head and neck cancer patients during that time.

The review found poorer outcomes were associated with race, poverty, age, gender, tumor site and stage, treatment type, and a history of smoking and alcohol consumption. 

Regarding race, the average survival time among Hispanics was 47 months, compared with 40 months among Caucasians and 21 months among African Americans. African American patients were diagnosed at a younger age and presented with more advanced disease compared with Caucasians. For all tumor stages, African American patients had a significantly shorter average survival time than Caucasians, regardless of poverty level. Treatments also differed between these two races: Caucasians were more likely than African Americans to have undergone surgery (45 percent vs. 32 percent), while African Americans were more likely than Caucasians to receive chemotherapy (26 percent vs. 19 percent) and radiation (66 percent vs. 56 percent). However, even among patients who received surgery, African Americans had a shorter survival time than Caucasians.

When assessing socioeconomic status, the investigators found that patients living in communities with poverty levels exceeding 15 percent were diagnosed with head and neck cancer at a significantly younger age, more frequently diagnosed with advanced disease, and had lower average survival was lower across all age groups. Average survival time was significantly shorter in patients from the areas with the highest poverty rates irrespective of what type of therapy was received.

The authors conclude that racial disparities continue to exist in head and neck cancer survival. Socio-economic inequities are also evident in head and neck cancer survival, even when the poor receive treatment for their disease.

“Earlier diagnosis, particularly in those from low socio-economic status groups and amongst African American patients, is needed to improve outcomes,” the authors wrote.

###

Article: “African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients.” Manuel A. Molina, Michael C. Cheung, Eduardo A. Perez, Margaret M. Byrne, Dido Franceschi, Frederick L. Moffat, Alan S. Livingstone, W. Jarrard Goodwin, Juan C. Gutierrez, and Leonidas G. Koniaris. CANCER; Published Online: October 06, 2008 (DOI: 10.1002/cncr.23889); Print Issue Date: November 15, 2008.

Contact: Lisa Worley, Director, Media Relations in the Office of Communications at the University of Miami Miller School of Medicine at 305-243-5184 or .

NOTE: The information contained in this release is protected by copyright. For more information or to obtain a PDF of any study, please contact:

David Sampson
American Cancer Society

Claire Greenwell
American Cancer Society

Contact: David Sampson

213-368-8523
American Cancer Society

RELATED STORIES:
Convergence in head and neck cancer   Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer   ‘Timing is everything’ in ensuring healthy brain development   Disparities among patients with extremity soft-tissue sarcomas   New Insight on Survival for Patients with Head and Neck Cancers   A new radiation therapy treatment developed for head and neck cancer patients   BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer   Genetic Risk Factor Found for Head and Neck Cancer in Smokers   New technique holds promise for rare eye cancer   Researchers Find Marker for Severity in Adult Brain Cancer   Does Green Tea Prevent Cancer? Evidence Continues to Brew, But Questions Remain   Do cell phones increase brain cancer risk?   Coffee may cut risk of head and neck cancers   Gene expression to distinguish metastasizing from non-metastasizing head and neck cancers   Rare Head and Neck Cancer Linked to HPV   Study Compares Treatment Options for Patients with Brain Metastases   Ten Minutes That Could Save Your Life   Vaccine against deadly brain cancer shows promise   Some brain tumors mimic the genetic program of germline cells   Could smoking pot cut risk of head, neck cancer?   Study finds no brain tumor link with mobile phones   Radiation better than surgery at preserving speech for patients with head and neck cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]